Our consulting team has significant experience with the data and analytics that are unique to US access, reimbursement, and pricing. We regularly work with retail and specialty pharmacy Rx data and integrate it with formulary, pricing, and contract invoice data to produce useful strategic and tactical insight.
Double Helix evaluates list pricing opportunities throughout a brand's lifecycle, including conducting robust quantitative research using conjoint methodologies prior to launch and advising on the magnitude and timing of list price increases as products approach their loss of exclusivity (LOE).
Net price rebate agreements are commonly used to improve formulary access or drive share in selected accounts. Our skilled team analyzes the impact of differential access on prescribing demand and develops channel-level or customer-specific contracting strategies, factoring in cross market implications such as spillover and Best Price. These recommendations help clients to maximize return on investment (ROI) and minimize total rebate liability.